These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 8858456

  • 21. Comparative activity of meropenem against Pseudomonas aeruginosa strains with well-characterized resistance mechanisms.
    Livermore DM, Yang YJ.
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():149-59. PubMed ID: 2553657
    [Abstract] [Full Text] [Related]

  • 22. Prevalence of decreased susceptibility to carbapenems among Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii and investigation of carbapenemases.
    Lee HK, Park YJ, Kim JY, Chang E, Cho SG, Chae HS, Kang CS.
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):331-6. PubMed ID: 15994052
    [Abstract] [Full Text] [Related]

  • 23. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
    Zhanel GG, Lawrence CK, Adam H, Schweizer F, Zelenitsky S, Zhanel M, Lagacé-Wiens PRS, Walkty A, Denisuik A, Golden A, Gin AS, Hoban DJ, Lynch JP, Karlowsky JA.
    Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
    [Abstract] [Full Text] [Related]

  • 24. Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins.
    Raimondi A, Traverso A, Nikaido H.
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1174-80. PubMed ID: 1656855
    [Abstract] [Full Text] [Related]

  • 25. Emergence of Serratia marcescens isolates possessing carbapenem-hydrolysing β-lactamase KPC-2 from China.
    Lin X, Hu Q, Zhang R, Hu Y, Xu X, Lv H.
    J Hosp Infect; 2016 Sep; 94(1):65-7. PubMed ID: 27160868
    [Abstract] [Full Text] [Related]

  • 26. SMB-1, a novel subclass B3 metallo-beta-lactamase, associated with ISCR1 and a class 1 integron, from a carbapenem-resistant Serratia marcescens clinical isolate.
    Wachino J, Yoshida H, Yamane K, Suzuki S, Matsui M, Yamagishi T, Tsutsui A, Konda T, Shibayama K, Arakawa Y.
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5143-9. PubMed ID: 21876060
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Alteration in expression of Serratia marcescens porins associated with decreased outer membrane permeability.
    Hashizume T, Sanada M, Nakagawa S, Tanaka N.
    J Antimicrob Chemother; 1993 Jan; 31(1):21-8. PubMed ID: 8444671
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A beta-lactamase, Sme-1, from Serratia marcescens S6.
    Naas T, Vandel L, Sougakoff W, Livermore DM, Nordmann P.
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1262-70. PubMed ID: 8092824
    [Abstract] [Full Text] [Related]

  • 33. Carbapenem resistance in a clinical isolate of Citrobacter freundii.
    Mainardi JL, Mugnier P, Coutrot A, Buu-Hoï A, Collatz E, Gutmann L.
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2352-4. PubMed ID: 9371332
    [Abstract] [Full Text] [Related]

  • 34. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C, Xie W, Zhang W, Ye Z, Wu H.
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [Abstract] [Full Text] [Related]

  • 35. Effect of clavulanic acid on activity of beta-lactam antibiotics in Serratia marcescens isolates producing both a TEM beta-lactamase and a chromosomal cephalosporinase.
    Bush K, Flamm RK, Ohringer S, Singer SB, Summerill R, Bonner DP.
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2203-8. PubMed ID: 1803992
    [Abstract] [Full Text] [Related]

  • 36. Selection of hyperproduction of AmpC and SME-1 in a carbapenem-resistant Serratia marcescens isolate during antibiotic therapy.
    Hemarajata P, Amick T, Yang S, Gregson A, Holzmeyer C, Bush K, Humphries RM.
    J Antimicrob Chemother; 2018 May 01; 73(5):1256-1262. PubMed ID: 29471486
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Carbapenem resistance in a clinical isolate of Enterobacter aerogenes is associated with decreased expression of OmpF and OmpC porin analogs.
    Yigit H, Anderson GJ, Biddle JW, Steward CD, Rasheed JK, Valera LL, McGowan JE, Tenover FC.
    Antimicrob Agents Chemother; 2002 Dec 01; 46(12):3817-22. PubMed ID: 12435682
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.